Company profile
Drug Free Solution, Inc.
OTC: DSOL · Healthcare · Medical - Healthcare Information Services
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 29
v0.1 · 5/100 weight · pillars only
↑ return on assets, listing tenure · ↓ 3-yr revenue growth, Altman-Z
Methodology →Revenue TTM
$2
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$6.7k
Employees
2
as of 2026-08-28
Market cap
$113.4k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02024
Net income-$6.7k-$6.7k2024
Operating income-$6.7k-$6.7k2024
Total assets$52.5k$52.5k2019
Liabilities$333.3k$333.3k2019
Equity-$280.8k-$280.8k2019
Revenue trend
FY2012 – FY2024 · USD
FY12
FY16
FY17
FY18
FY19
FY22
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Drug Free Solution, Inc.’s revenue?
Drug Free Solution, Inc. booked $0 in FY2024 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
NanoSphere Health Sciences Inc.——Many Bright Ideas Technologies Inc.——Priority Aviation, Inc.——Nascent Biotech, Inc.——ProtoKinetix, Incorporated——Digicann Ventures Inc.16DNeighbors
Los Angeles →Key facts
CEOJessica Bass
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersEl Segundo, CA
ExchangeOTC: DSOL
Employees2
IPO date2012-11-20
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.